ARCHIVES

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

This article is from The Cancer Letter archive.

Vol. 33 No. 04 | February 2, 2007

Download PDF Visit The Full Archive

Related Articles

Nixon Tells ACCC U.S., USSR Should Be Allies In War Against Cancer

April 11, 1986

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Abstracts of Papers From ASCO Meeting

April 14, 1978